| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/11/2003 | WO2003102184A1 Methods, compositions and kits for cell separation |
| 12/11/2003 | WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof |
| 12/11/2003 | WO2003102181A1 Method of detecting gene polymorphism |
| 12/11/2003 | WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY |
| 12/11/2003 | WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION |
| 12/11/2003 | WO2003102176A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 12/11/2003 | WO2003102174A2 Modified phytases |
| 12/11/2003 | WO2003102173A2 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 12/11/2003 | WO2003102169A1 Anaerobe targeted enzyme-mediated prodrug therapy |
| 12/11/2003 | WO2003102168A1 Attenuated listeria spp. and methods for using the same |
| 12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102160A2 Rationally designed polysaccharide lyases derived from chondroitinase b |
| 12/11/2003 | WO2003102157A2 Synthetic antibody phage libraries |
| 12/11/2003 | WO2003102155A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2003102152A2 Methods and materials for the production of lactic acid in yeast |
| 12/11/2003 | WO2003102146A2 Aptamer constructs |
| 12/11/2003 | WO2003102145A2 Glioma-specific transcription control nucleic acids |
| 12/11/2003 | WO2003102141A2 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003102137A2 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102131A2 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
| 12/11/2003 | WO2003102129A2 Photorhabdus luminescens mcf toxin genes and uses thereof |
| 12/11/2003 | WO2003102128A1 Maize nucleotide sequence coding for a protein with transglutaminase activity and use thereof |
| 12/11/2003 | WO2003102127A2 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | WO2003102126A1 A method of cell therapy using fused cell hybrids |
| 12/11/2003 | WO2003102125A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102027A1 Homotrimeric extended obg3 globular head and uses thereof |
| 12/11/2003 | WO2003102025A1 Protein inducing cell death of helicobacter pylori |
| 12/11/2003 | WO2003102023A1 Tumour-associated peptides that bond to mhc molecules |
| 12/11/2003 | WO2003102019A2 Antisense modulation of sterol regulatory element-binding protein-1 expression |
| 12/11/2003 | WO2003102017A2 Anti-relp fusion antibodies, compositions, methods and uses |
| 12/11/2003 | WO2003102011A1 Method for determining oligonucleotide concentration |
| 12/11/2003 | WO2003102008A1 Antisense modulation of transcription factor dp-1 expression |
| 12/11/2003 | WO2003101586A1 Cell recovery |
| 12/11/2003 | WO2003101497A1 Knockout mice and their use |
| 12/11/2003 | WO2003101494A1 Materials and methods relating to polyions and substance delivery |
| 12/11/2003 | WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003101189A1 Inducible eukaryotic expression system |
| 12/11/2003 | WO2003101184A2 Carotenoid synthesis |
| 12/11/2003 | WO2003101177A2 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 12/11/2003 | WO2003101176A2 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 12/11/2003 | WO2003101173A2 Immunomodulatory constructs and their uses |
| 12/11/2003 | WO2003091404A3 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 12/11/2003 | WO2003088925A3 Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
| 12/11/2003 | WO2003080823A3 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/11/2003 | WO2003080666A3 An adipocyte insulin and a method of treating diabetes |
| 12/11/2003 | WO2003076940A3 Acyl fluoride activation of carboxysilyl-coated glass substrates |
| 12/11/2003 | WO2003076463A3 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance |
| 12/11/2003 | WO2003074670A3 Lis promoter for expression of transgenes in floral tissues |
| 12/11/2003 | WO2003071861A3 Vanillin biosynthetic pathway enzyme from vanilla planifolia |
| 12/11/2003 | WO2003070882A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof |
| 12/11/2003 | WO2003066864A3 Method for predicting the expression efficiency in cell-free expression systems |
| 12/11/2003 | WO2003065977A3 Modified antigen-presenting cells |
| 12/11/2003 | WO2003064624A3 Molecular hepatotoxicology modeling |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 12/11/2003 | WO2003062462A3 Method for isolating nucleic acids and protein from a single sample |
| 12/11/2003 | WO2003057847A3 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003053857A9 Forming and modifying dielctrically-engineered microparticles |
| 12/11/2003 | WO2003052110A3 Nucleic acid nematicides |
| 12/11/2003 | WO2003051834A3 Immunocellular receptors related to neurological disorders |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003050296A3 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| 12/11/2003 | WO2003048369A3 Method of transforming intact plants |
| 12/11/2003 | WO2003048348A3 Production of viruses, viral isolates and vaccines |
| 12/11/2003 | WO2003048306A3 Polycistronic expression of antibodies |
| 12/11/2003 | WO2003045986A3 Purified polypeptides involved in general metabolism as possible drug targets |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
| 12/11/2003 | WO2003040365A3 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus |
| 12/11/2003 | WO2003040324A3 Methods for mutating genes in cells and animals using insertional mutagenesis |
| 12/11/2003 | WO2003038121A3 Method for the detection of cytosine methylation in immobilised dna samples |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods |
| 12/11/2003 | WO2003031616A3 Methods for dna mutagenesis and dna-cloning |
| 12/11/2003 | WO2003029486A3 Single nucleotide polymorphisms predicting cardiovascular disease |
| 12/11/2003 | WO2003029458A3 Method for producing protein libraries and for selecting proteins from said libraries |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003027326A3 Nucleic acid sequencing by raman monitoring of molecular deconstruction |
| 12/11/2003 | WO2003025220A3 Fusion proteins useful for detecting analytes |
| 12/11/2003 | WO2003025132A3 Dna polymerases and mutants thereof |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003020902A3 Methods for blocking nonspecific hybridizations of nucleic acid sequences |
| 12/11/2003 | WO2003020888A3 Constitutive photomorphogenesis 1 (cop1) nucleic acid sequence from zea mays and its use thereof |
| 12/11/2003 | WO2003012451A3 Methods for detecting of intermoleculair interactions using protein arrays |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003010311A3 Process for preparing variant polynucleotides |
| 12/11/2003 | WO2003008549A3 Antisense modulation of glioma-associated oncogene-3 expression |